Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViaGen Pets & Equine is a world leader in animal cloning and genetic preservation services, specializing in dogs, cats, and horses. The company utilizes advanced somatic cell nuclear transfer (SCNT) technology to provide clients with genetic twins of their animals. Beyond cloning, ViaGen offers long-term genetic preservation services, allowing owners to store tissue samples for future use. The company serves a diverse clientele ranging from pet owners seeking to maintain a connection with a beloved companion to equine professionals looking to preserve elite performance bloodlines. ViaGen operates as a subsidiary of Trans Ova Genetics and is headquartered in Texas. The company is also actively involved in conservation efforts, successfully cloning endangered species to aid in biodiversity preservation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViaGen Pets & Equine.